Skip to main content
Premium Trial:

Request an Annual Quote

Edge BioSystems Licenses Protein-Refolding Technology from KU Medical Center

NEW YORK, April 20 (GenomeWeb News) - Kansas University Medical Center has given Edge BioSystems a license to manufacture and use a protein-refolding technology that Edge plans to apply to drug discovery and diagnostics, the organizations said today.


Edge sees a "very broad range of applications for this technology," including large-scale functional assays for drug discovery, target validation, high-throughput screening, and possibly structural studies, Omayma Al-Awar, director of sales and marketing for Edge, told GenomeWeb News today. The company believes the technology will be useful to customers in academia and pharmaceutical companies, she added.


Al-Awar declined to disclose financial terms of the license.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more